232 related articles for article (PubMed ID: 25977529)
1. Infectious diseases. Ebola survivors fight back in plasma studies.
Enserink M
Science; 2015 May; 348(6236):742-3. PubMed ID: 25977529
[No Abstract] [Full Text] [Related]
2. Ebola raises profile of blood-based therapy.
Butler D
Nature; 2015 Jan; 517(7532):9-10. PubMed ID: 25557698
[No Abstract] [Full Text] [Related]
3. [Position on blood collection and use of convalescent plasma as a treatment option in the outbreak of severe infections].
Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1371-7. PubMed ID: 26487385
[No Abstract] [Full Text] [Related]
4. Treatment of Ebola virus infection with antibodies from reconvalescent donors.
Kreil TR
Emerg Infect Dis; 2015 Mar; 21(3):521-3. PubMed ID: 25695274
[TBL] [Abstract][Full Text] [Related]
5. Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever?
Takada A
Immunotherapy; 2013 May; 5(5):441-3. PubMed ID: 23638738
[No Abstract] [Full Text] [Related]
6. What motivates Ebola survivors to donate plasma during an emergency clinical trial? The case of Ebola-Tx in Guinea.
Ronse M; Marí Sáez A; Gryseels C; Bannister-Tyrrell M; Delamou A; Guillard A; Briki M; Bigey F; Haba N; van Griensven J; Peeters Grietens K
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006885. PubMed ID: 30332421
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic use of immune sera. Ebola survivors as lifesavers?].
Eickmann M; Schumacher B
MMW Fortschr Med; 2014 Nov; 156(19):6. PubMed ID: 25509993
[No Abstract] [Full Text] [Related]
8. The ongoing evolution of antibody-based treatments for Ebola virus infection.
Mendoza EJ; Racine T; Kobinger GP
Immunotherapy; 2017 Mar; 9(5):435-450. PubMed ID: 28357917
[TBL] [Abstract][Full Text] [Related]
9. Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea.
Delamou A; Haba NY; Mari-Saez A; Gallian P; Ronse M; Jacobs J; Camara BS; Kadio KJO; Guemou A; Kolie JP; Crop M; Chavarin P; Jacquot C; Lazaygues C; Weggheleire A; Lynen L; van Griensven J
Am J Trop Med Hyg; 2016 Sep; 95(3):647-653. PubMed ID: 27430546
[TBL] [Abstract][Full Text] [Related]
10. Ethical dilemma for Ebola drug trials.
Hayden EC
Nature; 2014 Nov; 515(7526):177-8. PubMed ID: 25391940
[No Abstract] [Full Text] [Related]
11. Infectious diseases. Ebola drugs still stuck in lab.
Enserink M
Science; 2014 Jul; 345(6195):364-5. PubMed ID: 25061181
[No Abstract] [Full Text] [Related]
12. Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections.
Kudoyarova-Zubavichene NM; Sergeyev NN; Chepurnov AA; Netesov SV
J Infect Dis; 1999 Feb; 179 Suppl 1():S218-23. PubMed ID: 9988187
[TBL] [Abstract][Full Text] [Related]
13. [Ebola: "survivors' blood" gets into the official therapeutic arsenal].
Nau JY
Rev Med Suisse; 2014 Sep; 10(442):1730-1. PubMed ID: 25322506
[No Abstract] [Full Text] [Related]
14. A Thought on Possible Pathogenesis of Ebola Viral Hemorrhagic Disease and Potential Treatments: Could it Be Thrombotic Thrombocytopenic Purpura-Like Syndrome?
Chang JC
Ther Apher Dial; 2016 Feb; 20(1):93-8. PubMed ID: 26626044
[No Abstract] [Full Text] [Related]
15. Clinical trials of Ebola therapies to begin in December.
Gulland A
BMJ; 2014 Nov; 349():g6827. PubMed ID: 25398534
[No Abstract] [Full Text] [Related]
16. Ebola virus convalescent blood products: where we are now and where we may need to go.
Burnouf T; Seghatchian J
Transfus Apher Sci; 2014 Oct; 51(2):120-5. PubMed ID: 25457751
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Ebola.
Deen J; Dondorp AM; White NJ
N Engl J Med; 2015 Apr; 372(17):1673-4. PubMed ID: 25901440
[No Abstract] [Full Text] [Related]
18. Treatment of Ebola.
Mehta AK; Lyon GM; Varkey JB
N Engl J Med; 2015 Apr; 372(17):1674. PubMed ID: 25901439
[No Abstract] [Full Text] [Related]
19. The use of convalescent plasma to treat emerging infectious diseases: focus on Ebola virus disease.
Winkler AM; Koepsell SA
Curr Opin Hematol; 2015 Nov; 22(6):521-6. PubMed ID: 26457963
[TBL] [Abstract][Full Text] [Related]
20. Ebola update.
Nunes-Alves C
Nat Rev Microbiol; 2014 Oct; 12(10):656. PubMed ID: 25226049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
